Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03668327 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Preterm Birth Cohort Study in Guangzhou

Study acronym: PBCSG
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 26, 2024 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary completion date: Dec 31, 2023 to Dec 31, 2025v5
  2. Re-verified, no change to tracked fieldsv4
  3. Primary completion date: Dec 31, 2020 to Dec 31, 2023v3
  4. Re-verified, no change to tracked fieldsv2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The Preterm Birth Cohort Study in Guangzhou (PBCSG) aims to explore the impact of genetic and environmental factors including life styles on preterm birth, to examine the interaction effect between these factors, and to follow up the short-term and long-term outcomes of preterm childrens.
Trial Details
NCT Number NCT03668327
Lead Sponsor Guangzhou Women and Children's Medical Center
Conditions
(from sponsor)		 Preterm Birth, Neurodevelopment, Immune Development, Host and Microbiome
Related terms Premature Birth
Enrollment 5,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov